Aleafia Health has completed production of its first white label production run of medical cannabis oils, for distribution in Australia. "The cannabis oils were produced at the Company’s Paris Processing Facility and will be distributed by Melbourne, Australia based Montu Group (“Montu Group”), leveraging their newly launched premium medical brand Circle," the team with the company explains.
"The transaction represents the first production run of Aleafia Health’s newly launched international white label production service, which leverages the Company’s proven formulas and international distribution channels."
“We are pleased to leverage our established Australian sales channel and new relationship with Montu Group in this fast growing medical cannabis market. With the strength of our existing local distribution network and investments, we are increasing our Australian footprint, as we also deploy our cannabis education platform and clinic operations expertise,” said Aleafia Health CEO Geoffrey Benic.
“The launch of our medical cannabis brand Circle in Australia is strengthened by Aleafia Health’s proven product expertise derived from their proprietary set of over 10 million patient-related data points,” said Montu Group Managing Director Christopher Strauch. “Australia is a core pillar of our international expansion strategy, as one of the leading and fastest growing medical cannabis markets in the world. This relationship marks an important milestone in supporting our growing network of doctors to access high quality cannabis products.”
"All necessary import permits from the Australian Department of Health have been secured, and the shipment is expected to be completed in late 2019, following receipt of necessary Health Canada export permits," they conclude.
For more information:
Aleafia Health
AleafiaHealth.com